TA328384
antibody from OriGene
Targeting: MIA2
cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, CTAGE5, FLJ22404, MEA6, MGEA, MGEA11, MGEA6, TALI
Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- ELISA [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- TA328384 - Provider product page
- Provider
- OriGene
- Product name
- Anti-Human MIA-2 Rabbit Polyclonal Antibody
- Antibody type
- Polyclonal
- Description
- Anti-Human MIA-2 Rabbit Polyclonal Antibody
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Epitope
- MIA2
- Isotype
- IgG
- Vial size
- 100ug
No comments: Submit comment
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- To detect hMIA-2 by sandwich ELISA (using 100ul/well antibody solution) a concentration of 0.5 - 2.0 ug/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with Biotinylated Anti-Human MIA-2 (TA328383) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hMIA-2.
- Validation comment
- WB
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- To detect hMIA-2 by sandwich ELISA (using 100ul/well antibody solution) a concentration of 0.5 - 2.0 ug/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with Biotinylated Anti-Human MIA-2 (TA328383) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hMIA-2.
- Validation comment
- ELISA
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- To detect hMIA-2 by sandwich ELISA (using 100ul/well antibody solution) a concentration of 0.5 - 2.0 ug/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with Biotinylated Anti-Human MIA-2 (TA328383) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hMIA-2.
- Validation comment
- IHC